机译:DINITOPENYL HAPTEN具有激光免疫疗法,用于晚期恶性黑色素瘤:临床研究
Chinese Peoples Liberat Army Gen Hosp Affiliated Hosp 1 Dept Oncol 51 Fucheng Rd Beijing 100048;
Chinese Peoples Liberat Army Gen Hosp Affiliated Hosp 1 Dept Oncol 51 Fucheng Rd Beijing 100048;
Chinese Peoples Liberat Army Gen Hosp Affiliated Hosp 1 Dept Oncol 51 Fucheng Rd Beijing 100048;
Chinese Peoples Liberat Army Gen Hosp Affiliated Hosp 1 Dept Oncol 51 Fucheng Rd Beijing 100048;
Chinese Peoples Liberat Army Gen Hosp Affiliated Hosp 1 Dept Oncol 51 Fucheng Rd Beijing 100048;
Chinese Peoples Liberat Army Gen Hosp Affiliated Hosp 1 Dept Oncol 51 Fucheng Rd Beijing 100048;
Chinese Peoples Liberat Army Gen Hosp Affiliated Hosp 1 Dept Oncol 51 Fucheng Rd Beijing 100048;
Chinese Peoples Liberat Army Gen Hosp Affiliated Hosp 1 Dept Oncol 51 Fucheng Rd Beijing 100048;
Chinese Peoples Liberat Army Gen Hosp Affiliated Hosp 1 Dept Oncol 51 Fucheng Rd Beijing 100048;
Chinese Peoples Liberat Army Gen Hosp Affiliated Hosp 1 Dept Oncol 51 Fucheng Rd Beijing 100048;
Univ Cent Oklahoma Dept Engn Phys Edmond OK 73034 USA;
malignant melanoma; metastasis; tumor immunity; dinitrophenyl; contact dermatitis; laser;
机译:DINITOPENYL HAPTEN具有激光免疫疗法,用于晚期恶性黑色素瘤:临床研究
机译:加拿大国家癌症研究所临床试验小组的一项研究,针对晚期恶性黑色素瘤患者的两种方案的溴代他汀-1(NSC339555)进行的随机II期研究。
机译:基于细胞的MAGE-A3主动免疫疗法治疗晚期黑色素瘤患者的临床研究
机译:光热疗法联合二硝基苯基半抗原治疗晚期恶性黑色素瘤
机译:利用统计を见る利用淋巴因子激活的杀伤(LAK)细胞进行局部过继免疫治疗的基础研究及其在恶性胶质瘤中的临床应用
机译:二硝基苯基半抗原激光免疫疗法治疗晚期恶性黑色素瘤的临床研究
机译:基于细胞的MAGE-A3主动免疫疗法治疗晚期黑色素瘤患者的临床研究